Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Vsee Health (VSEE) EBIAT (2023 - 2025)

Vsee Health filings provide 3 years of EBIAT readings, the most recent being -$7.9 million for Q4 2025.

  • On a quarterly basis, EBIAT fell 144.7% to -$7.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$14.7 million, a 75.29% increase, with the full-year FY2025 number at -$14.7 million, up 74.5% from a year prior.
  • EBIAT hit -$7.9 million in Q4 2025 for Vsee Health, down from -$289745.0 in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $94750.0 in Q1 2024 to a low of -$53.9 million in Q3 2024.
  • Median EBIAT over the past 3 years was -$2.5 million (2023), compared with a mean of -$6.9 million.
  • The widest YoY moves for EBIAT: up 117.88% in 2024, down 30314.72% in 2024.
  • Vsee Health's EBIAT stood at -$2.5 million in 2023, then fell by 28.01% to -$3.2 million in 2024, then crashed by 144.7% to -$7.9 million in 2025.
  • The last three reported values for EBIAT were -$7.9 million (Q4 2025), -$289745.0 (Q3 2025), and -$2.6 million (Q2 2025) per Business Quant data.